LABD · Direxion Daily S&P Biotech Bear 3X ETF
United States · RS rating 37 · As of 2026-10-14
| Price | 8.64 USD |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 94 / 66 / 7 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 26 / 5 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +75.3% |
| Market cap (USD) | – |